Article
Media Matters: Culture Medium-Dependent Hypervariable Phenotype of Mesenchymal Stromal Cells
2023-08-23
Abstract excerpt
<title>Abstract</title> <p>Background Despite a long history of investigation and sustained efforts in clinical testing, the number of market authorisations for mesenchymal stromal cell (MSC) therapies remains limited, with none approved by the United States Food and Drug Administration (FDA). Several barriers are impeding the clinical progression of MSC therapies, to the forefront of these is a lack of standard...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3269202e-f865-5a5c-afcc-03a4e674cf66
- DOI
- 10.21203/rs.3.rs-3249115/v1
